Navigation Links
Simons Foundation grant boosts brain tumor research
Date:2/1/2008

NEW YORK, January 31, 2008 A $10 million commitment from James H. and Marilyn H. Simons through the Simons Foundation will support preclinical initiatives undertaken as part of Memorial Sloan-Ketterings new Brain Tumor Center (BTC).

Established in 2007, the BTC is designed to achieve fundamental new insights into the molecular and cellular properties that drive tumor development and growth. Investigators plan to apply that knowledge to the creation of therapies that target cancer cells and the abnormal signaling pathways needed to maintain them.

With its emphasis on carrying discoveries from the basic and translational research laboratory all the way to clinical trials, the BTC offers the potential for meaningful progress against one of the most challenging forms of cancer.

We are grateful to Jim and Marilyn Simons for their foresight and generosity in helping to get the Brain Tumor Center off to a strong start, said Harold Varmus, Memorial Sloan-Ketterings President. The work to be done through the BTC is highly complex, but absolutely essential, and we welcome the Foundations support in moving forward.

The grant from the Simons Foundation will underwrite preclinical studies of new therapies to confirm that they produce their desired effect in animal models. There currently exists no drug pipeline developed specifically for gliomas, and such preclinical work is an essential step in the design of new therapies for use in humans.

Brain cancer poses a particular challenge to treatment, in part because of the difficulties involved in getting drugs to cross the blood-brain barrier, which physically shields the brain from chemicals circulating in the body. There are also concerns about the potential side effects of drugs that do succeed in entering the brain. The highly precise treatments developed through the BTC will be designed to destroy cancer cells while sparing nearby sensitive tissues an especially important consideration in dealing with the brain.

Helping to guide the development of the BTC have been three physicians who bring a breadth of expertise to the project: Lisa M. DeAngelis, Chair of the Department of Neurology, Philip H. Gutin, Chair of the Department of Neurosurgery, and Eric C. Holland, a neurosurgeon and member of the Sloan-Kettering Institutes Cancer Biology and Genetics Program who is the BTCs founding director.

My colleagues and I are overwhelmed by the confidence that the Simons Foundation has shown in the work of the Brain Tumor Center and in the collaborative spirit that is at its heart, said Dr. Holland. This gift provides solid footings for the program and will dramatically accelerate the development of its preclinical and clinical components, which together are key to identifying new therapeutic approaches.

The Simons Foundations support for the Brain Tumor Center extends its commitment to promoting innovation in mathematics, physics, and other sciences a commitment exemplified by its Autism Research Initiative, which supports wide-ranging neuroscience research with the goal of improving the diagnosis, treatment, and prevention of autism and related conditions. Indeed, work conducted through the BTC into the biology of gliomas which arise from supporting tissue known as glia has the potential to shed new light on the role of glial cells in autism and a variety of neurodegenerative and neurodevelopmental disorders.


'/>"/>

Contact: Christine Hickey
hickey1@mskcc.org
212-639-3573
Memorial Sloan-Kettering Cancer Center
Source:Eurekalert

Related medicine news :

1. The Chrysler Foundation and Kenosha Engine Plant Donate $100,000 to New YMCA Aquatics Center
2. The UV Foundation Announces February is Vitamin D Deficiency Month
3. Michael J. Fox Foundation awards up to $3 million to industry teams
4. AMERIGROUP Foundation Announces Winners of Word About Health Contest
5. Dannemiller Memorial Education Foundation and GR MedEd, Inc. Announce Oncology Summit: From Discovery to Delivery
6. Fernandez Appointed to Blue Cross Foundation Board
7. Inspector Hector(R), National Childrens Oral Health Foundation Kick Off Events for National Childrens Dental Health Month
8. Asthma Foundation Announces 2008 Asthma Capitals, Knoxville on Top Again
9. Helios Education Foundation Invests $6.5 Million in New Partnership with TGen
10. The Highmark Foundation Awards $4 Million in Highmark Healthy High 5 Grants to Two Nonprofit Organizations
11. American Legacy Foundation Comments on New York State Department of Health Petition to the FDA to Expand Consumer Access to Over the Counter Nicotine Medications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star ... , Millions of individuals in the United States and Canada wear eyeglasses. Once considered ... both correct vision and make a fashion statement. Even celebrities use glasses as a ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, a ... and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is ... to some of the world’s leading providers of cereal and other breakfast foods. Its ...
(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/26/2016)... Birmingham, Lake Orion, Clarkston, Michigan (PRWEB) , ... ... ... their direction with respect to fertility once they have been diagnosed with endometriosis. ... for tolerable intercourse but they also require a comprehensive approach that can help ...
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica ... Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs ... Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology: